Approval · Notice of Compliance 15097 · 2014
OCPHYL: Notice of Compliance 15097
Issued January 2, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15097
- Date
- January 2, 2014
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Product name change
- Therapeutic class
- Synthetic octapeptide analogue of somatostatin
- Canadian reference product
- SANDOSTATIN (Novartis Pharmaceuticals Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OCPHYL | Not yet assigned | — |
Medicinal ingredients
- OCTREOTIDE ACETATE 50 MCG per ML
- OCTREOTIDE ACETATE 100 MCG per ML
- OCTREOTIDE ACETATE 500 MCG per ML